SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-242613
Filing Date
2021-08-11
Accepted
2021-08-11 07:07:58
Documents
2
Period of Report
2021-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d180808d8k.htm 8-K 17760
2 EX-99.1 d180808dex991.htm EX-99.1 45798
  Complete submission text file 0001193125-21-242613.txt   64698
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 211161946
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences